(Q38929017)

English

Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer.

scientific article published on 15 December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Activated MET acts as a salvage signal after treatment with alectinib, a selective ALK inhibitor, in ALK-positive non-small cell lung cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

alectinib hydrochloride

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

Marco A de Velasco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Akihiro Kogita

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Yosuke Togashi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Hidetoshi Hayashi

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Eri Banno

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Masato Terashima

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kazuko Sakai

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Yoshihiko Fujita

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Shuta Tomida

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Yoshifumi Takeyama

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kiyotaka Okuno

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kazuhiko Nakagawa

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kazuto Nishio

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

15 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

International Journal of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1025-1030

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

10.3892/IJO.2014.2797

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

release_4qmtho6azfeaventr5fdkruiz4

1 reference

https://api.fatcat.wiki/v0/release/4qmtho6azfeaventr5fdkruiz4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25502629%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38929017&oldid=1835835302"